Financial
KYERON BV is financed for the launch of SYNOZ ONE and for the development of POWERCOL. New resources are being allocated to extend the product portfolio by sub-contracted development and to extend the distributors network. Current projects focus on the tissue regeneration and may be ready-for-market within the next 1 – 2 years.
KYERON focuses on regenerative biomedical devices for various specialisme. We offer bone graft substitutes, intra-articular hyaluronic acids, heamostatics among others. KYERON is also in research for new applications for the used materials and ingredients. Tissue regeneration is an area of interest.
Ownership
KYERON BV is privately owned.
For further information please contact KYERON BV
Investors
In case you are interested to invest capital in KYERON Medical Innovations, please contact us by email investors@kyeron.nl or by phone +31 (0)53 8510417